Aclarion, INC Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NASDAQ
Amanda M Williams, a Director of Aclarion, Inc., purchased 5,857 shares of common stock on August 17, 2026 for $2.73 per share.
NASDAQ
Gregory A Gould, CFO of Aclarion, Inc., purchased 10,000 shares of common stock on August 14, 2026 for $2.45 per share.
NASDAQ
Ryan Bond, a Director of Aclarion, Inc., purchased 21,122 shares of common stock on August 13, 2026 for $2.37 per share.
NASDAQ
William Wesemann, a Director of Aclarion, Inc., purchased 2,150 shares of common stock on August 13, 2026 for $2.34 per share.
NASDAQ
David K Neal, a Director of Aclarion, Inc., purchased 7,500 shares of common stock on August 13, 2026 for $2.40 per share.
NASDAQ
Brent Ness, Chief Executive Officer and a Director of Aclarion, Inc., purchased 5,234 shares of common stock on August 13, 2026 for $2.31 per share.
NASDAQ
Aclarion, Inc. Chief Strategy Officer Ryan Bond was granted 55,000 restricted stock units vesting in June 2027.
NASDAQ
Aclarion, Inc. Executive Chairman Jeffrey John Thramann was granted 100,000 restricted stock units vesting in 2027.
NASDAQ
Aclarion, Inc. director David K. Neal was granted 20,000 restricted stock units as part of the company's equity incentive plan.
NASDAQ
Director Stephen Deitsch was granted 20,000 restricted stock units in Aclarion, Inc. as part of the company's equity incentive plan.
NASDAQ
Director Scott Breidbart acquired 5,664 shares of Aclarion, Inc. common stock on the open market.
NASDAQ
Director David K. Neal acquired 2,500 shares of Aclarion common stock for $3.10 per share.
NASDAQ
Aclarion, Inc. reports a significant stock purchase by its CEO and Director, Brent Ness.
NASDAQ
Aclarion, Inc. Director William Wesemann purchased 1,562 shares of common stock on the open market.
NASDAQ
Aclarion, Inc.'s Chief Executive Officer and Director, Brent Ness, acquired 10 shares of common stock on the open market at $6.2 per share.
NASDAQ
Aclarion, Inc.'s CFO, Gregory A. Gould, was granted 17,000 stock options with an exercise price of $7.15, vesting over four years.